Flávio Cadegiani

Flávio Cadegiani is a Brazilian physician and researcher known for his involvement in studies related to proxalutamida, a drug that has not been approved for use in Brazil or other countries. During the COVID-19 pandemic, he was linked to irregular research practices concerning the drug's use against the virus, leading to investigations by the authorities. Cadegiani has maintained that he never advised the use of the drug outside of clinical research settings.